Artwork

Content provided by Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Alon Ben-Noon of NeuroSense Therapeutics

18:51
 
Share
 

Manage episode 337501904 series 3382134
Content provided by Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Alon Ben-Noon is the CEO and co-founder of NeuroSense Therapeutics, a clinical stage drug development company offering ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Avraham Hermon sat down with Alon in the NeuroSense offices in Herzliya. They discussed the inspiration for creating a new ALS treatment, how to create results using a small team, raising money, dealing with investors, the mentality of a startup founder, the role of patents in biotech companies and much more. Do you have a great innovation? We'd love to hear from you. Contact us by going to jmbdavis.com/startup/contact. Learn more at jmbdavis.com and jmbdavis.com/startup. Also available at https://soundcloud.com/jmbdavis/jeff-gabbay-of-argaman-technologies. Listen to all of the episodes at https://jmbdavis.com/podcast.
  continue reading

32 episodes

Artwork
iconShare
 
Manage episode 337501904 series 3382134
Content provided by Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Alon Ben-Noon is the CEO and co-founder of NeuroSense Therapeutics, a clinical stage drug development company offering ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Avraham Hermon sat down with Alon in the NeuroSense offices in Herzliya. They discussed the inspiration for creating a new ALS treatment, how to create results using a small team, raising money, dealing with investors, the mentality of a startup founder, the role of patents in biotech companies and much more. Do you have a great innovation? We'd love to hear from you. Contact us by going to jmbdavis.com/startup/contact. Learn more at jmbdavis.com and jmbdavis.com/startup. Also available at https://soundcloud.com/jmbdavis/jeff-gabbay-of-argaman-technologies. Listen to all of the episodes at https://jmbdavis.com/podcast.
  continue reading

32 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide